Viewing StudyNCT00085904



Ignite Creation Date: 2024-05-05 @ 11:34 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00085904
Status: COMPLETED
Last Update Posted: 2008-10-13
First Post: 2004-06-16

Brief Title: Dose-Escalating Study Of SB-485232 Administered Intravenously Every 28 Days To Adults With Solid Tumors Or Lymphomas
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Organization Data

Organization: GlaxoSmithKline
Class: INDUSTRY
Study ID: 485232003
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: GlaxoSmithKline
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: Study Director
Old Organization: GSK

Collaborators